MarketPulse
L

$LCTX

2 articles found
1 positive
0 negative
1 neutral
BenzingaBenzinga··Usa News Group

Biotech Race to Commercialize Longevity Science Heats Up as Market Eyes $29.7B Prize

Longevity biotech sector surges toward $29.7B market by 2034 as companies advance cell therapies for age-related diseases, with multiple clinical programs showing promising results.
VRTXLGVNLCTXOCGNclinical trialsgene therapy
BenzingaBenzinga··Equity-Insider.Com

Biotech Breakthrough: Avaí Bio Moves Anti-Aging Protein Therapy Into Production

Avaí Bio begins manufacturing genetically modified cells overexpressing α-Klotho protein, an anti-aging compound that naturally declines 50% after age 40, advancing its Cell-in-a-Box platform.
MESOMNKDLGVNAVAILCTXregenerative medicinecell therapy